Published in Vestn Oftalmol on February 17, 2011
Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern. Curr Treat Options Gastroenterol (2017) 0.75
[Oligodeoxyribonucleotides containing 2'-amino-2'-deoxypyrimidine nucleosides]. Bioorg Khim (1993) 0.87
[Pyrimidine oligodeoxyxylonucleotides form triplexes with purine DNA in neutral media]. Mol Biol (Mosk) (2002) 0.83
Targeting of single-stranded DNA and RNA containing adjacent pyrimidine and purine tracts by triple helix formation with circular and clamp oligonucleotides. Eur J Biochem (2000) 0.82
[Preparation of DNA-duplexes, containing internucleotide thiophosphate groups in various positions of the recognition site for the EcoRII restriction endonuclease]. Bioorg Khim (2004) 0.81
NF-kappaB p50 subunit cross-linking to DNA duplexes, containing a monosubstituted pyrophosphate internucleotide bond. FEBS Lett (1996) 0.79
Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System. Acta Naturae (2011) 0.79
Physico-chemical and biological properties of antisense phosphodiester oligonucleotides with various secondary structures. Nucleosides Nucleotides (1999) 0.79
[Computer search for novel HIV-1 integrase inhibitors]. Biomed Khim (2005) 0.78
[Natural substrates of uridylylpolynucleotide-(5'P--->O)-tyrosine phosphodiesterase--an enzyme, hydrolyzing the covalent bond between RNA and picornaviral VPg and a synthetic model of them]. Biokhimiia (1996) 0.78
[Chemical reactions in double-stranded nucleic acids. VI. N-hydroxybenzotriazole esters of oligonucleotides--reagents for synthesis of DNA-duplexes with modified sugar-phosphate backbone]. Bioorg Khim (1988) 0.78
Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects. Acta Naturae (2011) 0.78
[HIV-1 integrase inhibition by dimeric bisbenzimidazoles having different spacers]. Mol Biol (Mosk) (2010) 0.77
Relative Comparison of Catalytic Characteristics of Human Foamy Virus and HIV-1 Integrases. Acta Naturae (2009) 0.76
Structural-Functional Analysis of 2,1,3-Benzoxadiazoles and Their N-oxides As HIV-1 Integrase Inhibitors. Acta Naturae (2013) 0.76
[Kinetic modeling of the mechanism of allosteric interactions of restriction endonuclease EcoRII with two DNA segments]. Biokhimiia (1996) 0.76
[RNA synthesis by T7 RNA polymerase supported primer extension]. Mol Biol (Mosk) (2004) 0.76
[Multidrug resistance P-glycoprotein inhibits the antiapoptotic action of mitochondria-targeted antioxidant SkQR1]. Tsitologiia (2011) 0.75
[Solid phase synthesis and chromatographic characteristics of nucleophilic agents conjugated with oligonucleotides containing 5'-terminal carboxyl group]. Bioorg Khim (2003) 0.75
[Hybridase cleavage of RNA. III. Use of UV-spectroscopy for studying the kinetic properties of E. coli RNAase properties]. Biokhimiia (1991) 0.75
[Synthesis of modified oligodeoxyribonucleotides containing 9-(2'-amino-2'-deoxy-beta-D-arabinofuranosyl)adenine]. Bioorg Khim (1997) 0.75
[Synthesis of nucleotide derivatives containing 1-(4-(3-(trifluoromethyl)-3H-diazirin-3-yl)benzamido)-2,3-propanediol for photoaffinity modification of proteins and nucleic acid]. Bioorg Khim (2002) 0.75
[Cyclic oligonucleotides. III. Ability to form triplexes with oligodeoxyribonucleotides, consisting of mixed pyrimidine and purine sequences]. Mol Biol (Mosk) (1998) 0.75
[Theoretical approaches for evaluation of DNA-protein interactions]. Biofizika (2001) 0.75
Derivatization and template-guided ligation of oligodeoxyribonucleotides using cyanogen bromide and N-substituted morpholines. Orig Life Evol Biosph (1997) 0.75
[The search of novel inhibitors of HIV-1 integrase among 5-(4-halogenophenyl)-5-oxopentyl derivatives of nucleic bases]. Bioorg Khim (2015) 0.75
[Interaction of RNAase H from E. coli with modified hybrid duplexes. I. Duplexes modified at the carbohydrate residue]. Bioorg Khim (1994) 0.75
Restriction endonucleases can be used to confirm a structure of unusual DNA duplexes. Biol Chem (1998) 0.75
[DNA sequence-specific ligands: XIII. New Dimeric Hoechst 33258 molecules, inhibitors of HIV-1 integrase in vitro]. Bioorg Khim (2008) 0.75
Oligonucleotides conjugated with acridine: a new type of fluorescence probes for DNA hybridization assay. Dokl Biochem Biophys (2004) 0.75
[Cyclic oligonucleotides. II. Regularities in the formation of polycyclic structures]. Bioorg Khim (1997) 0.75
[Interactions of HIV-1 DNA heterocyclic bases with viral DNA]. Mol Biol (Mosk) (2004) 0.75
[HIV-1 integrase inhibition by modified oligonucleotides: optimization of the inhibitor structure]. Mol Biol (Mosk) (2007) 0.75
[Dimeric bisberzimidazoles: cytotoxicity and effects on DNA methylation in normal and cancer human cells]. Mol Biol (Mosk) (2013) 0.75
[Interaction of RNAase H from E. coli with modified duplexes. II. Duplexes, containing oligo(1-beta-D-2'-deoxy-threo-pentofuranosyl)thymidylate]. Mol Biol (Mosk) (1996) 0.75
[Synthesis and properties of DNA duplexes with covalent bonds between cross-links]. Bioorg Khim (1996) 0.75
[Multidrug resistance p-glycoprotein inhibits the antiapoptotic action of mitochondria-targeted antioxidant SkQR1]. Tsitologiia (2010) 0.75
[Chemical reactions in double-stranded nucleic acids. V. Directed introduction into the DNA sugar-phosphate backbone of aliphatic diamine or glycol residues]. Bioorg Khim (1988) 0.75
[Study of the mechanism of chemical ligation of DNA by cyanogen bromide]. Bioorg Khim (1995) 0.75
[Design of new oligonucleotide derivatives resistant to cell nucleases]. Bioorg Khim (1990) 0.75
[Interaction of cobalt phthalocyanine complex with DNA duplexes]. Mol Biol (Mosk) (2000) 0.75
[Approaches towards directed DNA integration by the use of retroviral integrases and transposases]. Mol Biol (Mosk) (2012) 0.75
[Antisense oligonucleotides containing 1-(beta-D-2'-deoxy-threo-pentofuranosyl)thymine at the 3'- and 5'-end]. Bioorg Khim (1994) 0.75
[Synthesis of modified oligonucleotides and use of a duplex from them with covalently bound chains]. Bioorg Khim (1995) 0.75
[Oligodeoxyribonucleotides containing 1-(beta-D-3'-deoxy-threo-pentofuranosyl)pyrimidine chains]. Bioorg Khim (1995) 0.75
[Synthesis and properties of a symmetric dimeric bisbenzimidazole, a DNA-specific ligand]. Bioorg Khim (2008) 0.75